Profile
ISPC DHR-PB TMO DHR IQV IDXX
Company Name iSpecimen Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $2.52M $916.76B $220.40B $185.44B $43.84B $41.07B
Employees 0.05K 79.00K 122.00K 61.00K 87.00K 11.00K
CEO Ms. Tracy Wilson Curley Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Jonathan J. Mazelsky
Ratings
ISPC DHR-PB TMO DHR IQV IDXX
Quant Rating Score 2 5 5 4 5 5
Quant Rating Sell Strong Buy Strong Buy Buy Strong Buy Strong Buy
Trading
ISPC DHR-PB TMO DHR IQV IDXX
Last Close $0.2778 $1261.26 $577.39 $250.41 $240.84 $494.26
High 52 $1.74 $1261.26 $599.43 $265.59 $259.1 $576.87
Low 52 $0.21 $1261.26 $431.41 $185.1 $177.16 $391.37
Price vs. 52 Week High -84.03 % 0 % -3.68 % -5.72 % -7.05 % -14.32 %
Price vs. 52 Week Low 32.29 % 0 % 33.84 % 35.28 % 35.94 % 26.29 %
Total Return
ISPC DHR-PB TMO DHR IQV IDXX
1 Month Return 10.55 % 0 % 0.67 % 1.05 % -3.23 % -6.69 %
3 Month Return -40.89 % 0 % 7.28 % 10.12 % 11.76 % -5.39 %
6 Month Return -52.28 % 0 % 33.29 % 29.98 % 32.9 % 19.77 %
9 Month Return -79.57 % 0 % 1.14 % -2.07 % 4 % -11.21 %
YTD Return -44.51 % 0 % 8.78 % 8.24 % 4.09 % -10.95 %
1 Year Return -83.16 % 0 % 5.29 % 7.94 % 25.63 % 2.28 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ISPC DHR-PB TMO DHR IQV IDXX
Dividend Yield Percentage (TTM) - 0.42 % 0.25 % 0.42 % - -
Dividend Paid and Capex Coverage Ration (TTM) -1.22 % 3.16 % 5.03 % 2.85 % 3.31 % 6.78 %
Dividend Per Share (TTM) - 1.05 % 1.44 % 1.05 % - -
Payout Ratio (TTM) - 17.87 % 6.73 % 23.72 % - -
Growth
ISPC DHR-PB TMO DHR IQV IDXX
Asset Growth -35.74 % 0.16 % 1.62 % 0.16 % 5.3 % 18.68 %
Gross Profit Growth -46.11 % -25.94 % -21.93 % -25.94 % -17.76 % 9.26 %
Revenue Growth -4.56 % -24.09 % -4.58 % -24.09 % 4.13 % 8.72 %
Revenue 3 Year -43.08 % 2.8 % 36.47 % 2.8 % 37.49 % 38.96 %
Revenue 5 Year 6 % 14.24 % 83.24 % 14.24 % 59.72 % 72.97 %
Revenue 10 Year 6 % 18.09 % 205.6 % 18.09 % 98.74 % 240.27 %
EBIT Growth -9.65 % -40.12 % -12.81 % -40.12 % 15.73 % 22.07 %
Net Income Growth -22.77 % -33.92 % -13.74 % -33.92 % 24.47 % 24.44 %
Net Income 3 Yeari Growth Per Share 22.94 % 25.29 % -3.52 % 25.29 % 406.6 % 49.23 %
Net Income 5 Yeari Growth Per Share 2.6 % 70.95 % 112.51 % 70.95 % 481.09 % 134.38 %
Net Income 10 Yeari Growth Per Share 2.6 % 67.05 % 339.48 % 67.05 % 304.81 % 475.93 %
Operating Income Growth -9.65 % -40.12 % -12.81 % -40.12 % 15.73 % 22.07 %
Operating Cash Flow Growth (CFG) 0.17 % -15.91 % -8.17 % -15.91 % -4.91 % 66.95 %
Operating 3 Year CFG -844.98 % 10.65 % 4.04 % 10.65 % 14.18 % 43.71 %
Operating 5 Year CFG -1.62 % 69.44 % 92.7 % 69.44 % 89.93 % 136.94 %
Operating 10 Year CFG -1.62 % 88.83 % 290.23 % 88.83 % 265.29 % 371.66 %
EPS Growth -20.59 % -34.29 % -12.41 % -34.29 % 26.98 % 25.25 %
EPS Diluted Growth -20.59 % -33.95 % -12.41 % -33.95 % 27.45 % 25.28 %
Book Value Per Share -53.08 % 5.14 % 7.9 % 5.14 % 8.21 % 145.51 %
Share Holder 3 Year Equity Growth Per Share 116.76 % 28.97 % 38.91 % 28.97 % 6.01 % 141.3 %
Share Holder 5 Year Equity Growth Per Share 124.81 % 80.33 % 76.4 % 80.33 % 0.89 % 16418.79 %
Share Holder 10 Year Equity Growth Per Share 124.81 % 125.79 % 158.74 % 125.79 % 718.56 % 266.68 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % - -
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % -100 % -100 %
Dividend 5 Year Growth Per Share - 174.17 % 104.77 % 174.17 % -100 % -
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % -100 % -
Debt Growth 5.59 % -0.72 % 1.24 % -0.72 % 9.38 % -29.7 %
Free Cash Flow Growth -17.13 % -21.53 % 0.23 % -21.53 % -5.42 % 96.09 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
ISPC DHR-PB TMO DHR IQV IDXX
Gross Profit Margin TTM 46.04 % 58.45 % 41.41 % 65.07 % 33.04 % 59.82 %
Return on Assets TTM -69.44 % 5.33 % 6.21 % 5.28 % 5.09 % 25.92 %
Return on Equity TTM -79.54 % 8.42 % 13.31 % 8.34 % 23.02 % 71.66 %
Return on Capital Employed TTM -114.32 % 7.39 % 8.37 % 5.54 % 10.08 % 47.53 %
Net Income Per EBT TTM 98.97 % 83.98 % 92.49 % 97.45 % 93.08 % 79.63 %
EBT Per Ebit TTM 99.37 % 94.74 % 93.75 % 107.86 % 71.7 % 96.72 %
EBIT Per Revenue TTM -112.5 % 21.3 % 16.38 % 20.72 % 13.54 % 29.97 %
Cash Flow To Debt Ratio TTM -2959.35 % 36.11 % 25.07 % 38.3 % 15.6 % 95.64 %
Receivables Turnover TTM 3.38 7.76 5.36 5.98 4.4 8
Payables Turnover TTM 1.36 6.49 - 4.2 2.82 13.29
Inventory Turnover TTM - 4.12 4.85 2.67 - 3.87
Fixed Asset Turnover TTM 3086.7 % 463.28 % 455.73 % 443.01 % 1834.55 % 521.37 %
Asset Turnover TTM 62.76 % 31.45 % 43.76 % 24.23 % 56.31 % 112.3 %
Operating Cash Flow Per Share TTM -0.64 9.27 23.37 9.39 11.81 10.91
Free Cash Flow Per Share TTM -1.16 7.39 19.79 7.5 8.25 9.3
Cash Per Share TTM 55.11 % 937.04 % 1897.91 % 949.37 % 822.43 % 546.33 %
Operating Cash Flow Sales Ratio TTM -58.5 % 26.52 % 21.01 % 34.42 % 14.3 % 24.76 %
Free Cash Flow Operating Cash Flow Ratio TTM 181.7 % 79.76 % 84.68 % 79.89 % 69.8 % 85.26 %
Cash Flow Coverage Ratios TTM -2959.35 % 36.11 % 25.07 % 38.3 % 15.6 % 95.64 %
Price To Free Cash Flows Ratio TTM -0.24 33.42 29.15 33.37 29.22 53.14
Price To Operating Cash Flows Ratio TTM -0.43 27.01 24.7 26.66 20.39 45.3
Price Cash Flow Ratio TTM -0.43 27.01 24.7 26.66 20.39 45.3
Income Statement (TTM)
ISPC DHR-PB TMO DHR IQV IDXX
Revenue $0.01B $23.89B $42.86B $23.89B $15.01B $3.66B
Gross Profit $0B $14.03B $15.22B $14.03B $4.14B $2.19B
Gross Profit Ratio 30.64% 58.74% 35.52% 58.74% 27.56% 59.82%
EBITDA $-0.01B $7.76B $10.72B $7.76B $3.21B $1.1B
Net Income $-0.01B $4.76B $6B $4.76B $1.36B $0.85B
EPS Diluted -1.23 6.38 15.45 6.38 7.29 10.06
Balance Sheet (MRQ)
ISPC DHR-PB TMO DHR IQV IDXX
Long Term Debt $0B $17.66B $31.31B $17.66B $12.96B $0.62B
Total Liabilities $0.01B $31B $51.88B $31B $20.57B $1.78B
Total Equity $0.01B $53.49B $46.84B $53.49B $6.11B $1.48B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.06B
Total Debt $0B $19.54B $34.92B $19.54B $14.23B $0.95B
Total Assets $0.02B $84.49B $98.73B $84.49B $26.68B $3.26B
Cash Flow Statement (TTM)
ISPC DHR-PB TMO DHR IQV IDXX
Net Income $-0.01B $4.22B $6B $4.22B $1.36B $0.85B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $0B $0B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $2.15B $0.91B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 136.32
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 5
AWH Aspira Women's Health Inc. 3.29
BDSX Biodesix, Inc. 1.245
BIAF bioAffinity Technologies, Inc. 2.41
BIAFW bioAffinity Technologies, Inc. 0.45
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.7501
BNR Burning Rock Biotech Limited 0.8501
CDNA CareDx, Inc 7.56
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.27
CNTG Centogene N.V. 0.4799
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 227.69
CSTL Castle Biosciences, Inc. 19.5
DGX Quest Diagnostics Incorporated 135.45
DHR Danaher Corporation 245.82
ETFs With Exposure to ISPC
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 249.41
VXF Vanguard Extended Market Index Fund 0 165.2
VTSAX Vanguard Total Stock Market Index Fund 0 121.97
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 125.97
VITSX Vanguard Total Stock Market Index Fund 0 121.99
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 125.98
VEMPX Vanguard Extended Market Index InstlPlus 0 310.88
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 228.81
Unlock